Introduction {#sec1}
============

Since the first modified RNA ribonucleic acid was found ∼60 years ago,[@bib1] ∼150 known RNA modifications have been reported.[@bib2] Emerging evidences suggest that RNA modifications are critical components of the gene regulatory landscape and are involved in a variety of biological processes in the post-transcriptional level, such as protein translation and localization,[@bib3] mRNA splicing,[@bib4] affecting ribosome biogenesis,[@bib5] mediating antibiotic resistance,[@bib6] and stem cell pluripotency.[@bib7] However, many aspects of RNA modifications remain unknown.[@bib8] Therefore, detecting the positions of RNA modifications plays an essential role for understanding their molecular mechanisms and functions.

The advent of next-generation sequencing technologies has allowed investigation of RNA modifications on a genome-wide scale.[@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15] For example, the *N*^1^-methyladenosine (m^1^A),[@bib9], [@bib10] *N*^6^-methyladenosine (m^6^A),[@bib13] and 5-methylcytosine (m^5^C)[@bib15] maps are available for the human transcriptome. Although these experimental methods played active roles in promoting the research progress on understanding the biological functions and the identification of RNA modifications, they are still labor-intensive. As excellent complements to experimental techniques, some computational methods (based on the high-resolution experimental data) have been developed to identify RNA modifications.[@bib7], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21]

Reminiscent of the regulation of gene expression by histone modifications, it is also possible to mediate biological functions in a collective way by combining different kinds of RNA modifications.[@bib8] Unfortunately, to the best of our knowledge, no computational tool is available for dealing with a system that simultaneously contains several different kinds of RNA modifications. Actually, this kind of multi-modification systems may contain much more interesting things worthy of exploration.

In view of this, the present study was initiated in an attempt to fill such a void by establishing a seamless package or platform that can be used to analyze a biological system that simultaneously contains the three well known types of RNA modifications: m^1^A, m^6^A, and m^5^C ([Figure 1](#fig1){ref-type="fig"}).Figure 1A Schematic Drawing to Show the Three Types of Modifications that May Simultaneously Occur in an RNA SequenceThree types of modifications (m^1^A, m^6^A, and m^5^C) are shown.

Results and Discussion {#sec2}
======================

By incorporating collective effects of nucleotides into PseKNC,[@bib22], [@bib23] a seamless platform called "iRNA-PseColl" has been developed for identifying the occurrence sites of different RNA modifications.

It has been observed by the most rigorous cross-validation, the jackknife test,[@bib24] that the success rates achieved by the new predictor are quite high for the three different types of RNA modification sites, respectively ([Table 1](#tbl1){ref-type="table"}).Table 1The Success Rates Obtained by the Proposed Model in Identifying Three Different Types of RNA Modification SitesModification TypeMetrics[a](#tblfn1){ref-type="table-fn"}Sn (%)Sp (%)Acc (%)MCC(1) m^1^A98.3899.8999.130.98(2) m^6^A81.8699.1190.380.82(3) m^5^C75.8379.1777.500.55[^1][^2]

Because it is the first platform predictor ever developed for simultaneously identifying three different types of RNA modification sites based on its sequence information alone, it is not possible to demonstrate its power by a comparison with its counterparts because there is no such a counterpart yet for exactly the same purpose. Nevertheless, as we can see from [Table 1](#tbl1){ref-type="table"}, all the scores are quite high, particularly for the overall accuracy (Acc) and Mathew's correlation coefficient (MCC).

Let us use graphic analysis to further demonstrate the proposed platform's quality. As it is, the graphical approach is a useful vehicle for studying complicated biological systems because it can provide intuitive insights, as demonstrated by a series of previous studies.[@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34] Therefore, it would be instructive and illuminative to give an intuitive illustration for the current study as well. To realize this, the graph of receiver operating characteristic (ROC)[@bib35], [@bib36] was adopted as shown in [Figure 2](#fig2){ref-type="fig"}, where the ROC curves for the current method in identifying m^1^A, m^6^A, and m^5^C modifications were given, respectively. The best possible prediction method would yield a point with the coordinate (0, 1) representing 100% sensitivity and 0 false-positive rate or 100% specificity. Therefore, the (0, 1) point is also called a perfect classification. A completely random guess would give a point along a diagonal from the point (0, 0) to (1, 1). The area under the ROC curve, also called AUROC, is used to indicate the performance quality of the classifier: the value 0.5 of AUROC is equivalent to random prediction while 1 of AUROC represents a perfect one. The AUROC for the case of m^1^A, m^6^A, or m^5^C is 0.998, 0.849, or 0.911, respectively, indicating that the proposed platform is quite promising, holding very high potential to become a useful high throughput tool for genome analyses.Figure 2A Graphical Illustration to Show the Performances of iRNA-PseColl in Identifying m^1^A, m^6^A, and m^5^C Modification Sites, RespectivelyThe performances are illustrated by means of the ROC curves.[@bib35], [@bib36] The area under the ROC curve is called AUROC. The greater the AUROC value is, the better the performance will be. See the text for further explanation.

Inspired by a series of recent publications,[@bib20], [@bib21], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45], [@bib46], [@bib47], [@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53] papers published with a publicly accessible web server will significantly enhance their impacts; this is particularly true for those papers aimed at developing novel prediction methods.[@bib54] Accordingly, the web server for the current platform has been established. Moreover, for the convenience of the scientific community, a user guide is given in the [Supplemental Materials and Methods](#mmc1){ref-type="supplementary-material"}.

Materials and Methods {#sec3}
=====================

According to the Chou's[@bib55] five-step guidelines that have been followed by many investigators in a series of recent publications,[@bib21], [@bib39], [@bib41], [@bib43], [@bib44], [@bib45], [@bib46], [@bib47], [@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib56], [@bib57], [@bib58], [@bib59], [@bib60], [@bib61], [@bib62], [@bib63] to develop a new prediction method that not only can be easily used by most experimental scientists but also can inspire theoretical scientists to develop many other relevant prediction methods, we should make the following five procedures very clear: (1) how to construct or select a valid benchmark dataset to train and test the prediction model, (2) how to represent a biological sequence sample with a mathematical formulation or vector that is really correlated with the target concerned, (3) how to introduce or develop a powerful engine (or algorithm) to run the prediction model, (4) how to properly perform the cross-validation tests to objectively evaluate the anticipated accuracy, and (5) how to design a user-friendly web server to make it easy for people to get their desired results. Below, we elaborate the five procedures in establishing the new predictor.

Benchmark Dataset {#sec3.1}
-----------------

Owing to the fast development of high-throughput experimental techniques, the experimentally confirmed m^1^A, m^6^A, and m^5^C modification data is available for the human genome.[@bib9], [@bib10], [@bib13], [@bib15] By mapping the experimental data to the human genome, the sequence samples with statistical significance were obtained for the three kinds of RNA modification sites as well. For facilitating the formulation, let us use the following scheme to represent a potential RNA modification-site-containing sample$$\text{R}_{\text{ξ}}\left( \circledast \right) = \text{N}_{- \text{ξ}}\text{N}_{- {({\text{ξ} - 1})}}\cdots\text{N}_{- 2}\text{N}_{- 1}\circledast\text{N}_{+ 1}\text{N}_{+ 2}\cdots\text{N}_{+ {({\text{ξ} - 1})}}\text{N}_{+ \text{ξ}},$$where the symbol $\circledast$ denotes the single nucleic acid code A (adenine) or C (cytosine), the subscript $\text{ξ}$ is an integer, $\text{N}_{- \text{ξ}}$ represents the $\text{ξ}$ -th upstream nucleotide from the center, the $\text{N}_{+ \text{ξ}}$ represents the $\text{ξ}$ -th downstream nucleotide, and so forth. The $\left( {2\text{ξ} + 1} \right)$ -tuple RNA sample, $\text{R}_{\text{ξ}}\left( \circledast \right)$, can be further classified into the following two categories:$$\mathbf{R}_{\text{ξ}}\left( \circledast \right) \in \left\{ \begin{array}{l}
{\mathbf{R}_{\text{ξ}}^{+}\left( \circledast \right),\quad\text{if}\ \text{its}\ \text{center}\ \text{can}\ \text{be}\ \text{of}\ 2^{\prime}\text{-}\text{O}\text{-}\text{methylation}} \\
{\mathbf{R}_{\text{ξ}}^{-}\left( \circledast \right),\quad\text{otherwise}} \\
\end{array} \right.,$$where $\text{R}_{\text{ξ}}^{+}\left( \circledast \right)$ denotes a true modification segment with A or C at its center, $\text{R}_{\text{ξ}}^{-}\left( \circledast \right)$ denotes a false modification segment with A or C at its center, and the symbol $\in$ means "a member of" in the set theory.

In literature, the benchmark dataset usually consists of a training dataset and a testing dataset: the former is for the use of training a model, while the latter for testing the model. However, as elucidated in a comprehensive review,[@bib64] there is no need to artificially separate a benchmark dataset into the aforementioned two parts if the prediction model is examined by the jackknife test or subsampling (K-fold) cross-validation, because the outcome thus obtained is actually from a combination of many different independent dataset tests. Thus, the benchmark datasets for the current study can be further formulated as$$\left\{ \begin{matrix}
{\mathbb{S}_{\text{ξ}}\left( {\text{m}^{1}\text{A}} \right) = \mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{1}\text{A}} \right) \cup \mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{1}\text{A}} \right),\quad\text{when}\ \circledast = \text{A}} \\
\begin{matrix}
{\mathbb{S}_{\text{ξ}}\left( {\text{m}^{6}\text{A}} \right) = \mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{6}\text{A}} \right) \cup \mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{6}\text{A}} \right),\quad\text{when}\ \circledast = \text{A}} \\
{\mathbb{S}_{\text{ξ}}\left( {\text{m}^{5}\text{C}} \right) = \mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{5}\text{C}} \right) \cup \mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{5}\text{C}} \right),\quad\text{when}\ \circledast = \text{C}} \\
\end{matrix} \\
\end{matrix} \right.,$$where the positive subset $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{1}\text{A}} \right)$ only contains those RNA samples that can have $\text{m}^{1}\text{A}$ modification, and the negative subset $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{1}\text{A}} \right)$ only contains those RNA samples that cannot have $\text{m}^{1}\text{A}$ modification, while $\text{U}$ denotes the symbol of "union" in the set theory,[@bib64] and so forth.

The benchmark datasets were derived from the RNA sequences in human genome that have the experimentally confirmed m^1^A, m^6^A, and m^5^C modification sites.[@bib9], [@bib10], [@bib13], [@bib15] The detailed procedures to construct the benchmark dataset are as follows. First, as done in Chou,[@bib65] by sliding the $\left( {2\text{ξ} + 1} \right)$ -tuple nucleotide window ([Figure 3](#fig3){ref-type="fig"}) along each of the aforementioned RNA sequences, only those RNA segments with $\circledast =$ A or C at the center were collected. Second, if the upstream or downstream in a RNA sequence was less than ξ or greater than $L - \text{ξ}$ where *L* is the length of the RNA sequence concerned, the lacking code was filled with the same code of its nearest neighbor. Third, the RNA segment samples thus obtained were put into the positive subset $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{1}\text{A}} \right)$, $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{6}\text{A}} \right)$, or $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{5}\text{C}} \right)$ if their centers were experimentally annotated as the m^1^A, m^6^A, or m^5^C sites; otherwise, into the corresponding negative subset $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{1}\text{A}} \right)$, $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{6}\text{A}} \right)$, or $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{5}\text{C}} \right)$. Fourth, to reduce redundancy and bias, none of the included RNA segments had pairwise sequence identity with any other in a same subset. By strictly following the above procedures, we obtained an array of benchmark datasets with different $\text{ξ}$ values and hence different lengths of RNA samples $\left( {2\xi + 1\ } \right)$ as well (see [Equation 1](#fd1){ref-type="disp-formula"}), as illustrated below$$\mathbb{S}_{\text{ξ}}\left( \circledast \right) \subset \left\{ \begin{matrix}
{23\ \text{nucleotides},\text{when}\ \text{ξ} = 11\ } \\
{25\ \text{nucleotides},\text{when}\ \text{ξ} = 12\ } \\
{27\ \text{nucleotides},\text{when}\ \text{ξ} = 13\ } \\
 \vdots \\
{39\ \text{nucleotides},\text{when}\ \text{ξ} = 19\ } \\
{41\ \text{nucleotides},\text{when}\ \text{ξ} = 20\ } \\
{43\ \text{nucleotides},\text{when}\ \text{ξ} = 21\ } \\
\end{matrix} \right.,$$where the symbol $\subset$ means "formed by." It was observed via preliminary tests as well as many reports[@bib19], [@bib43], [@bib66] that when $\text{ξ} = 20$ (i.e., the RNA samples formed by 41 nucleotides \[nt\]), the corresponding results were most promising. Accordingly, hereafter we only consider the 41-nt RNA sequences. By doing so, we obtained 6,366, 1,130 and 120 sequence samples for the positive subsets $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{1}\text{A}} \right)$, $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{6}\text{A}} \right)$, and $\mathbb{S}_{\text{ξ}}^{+}\left( {\text{m}^{5}\text{C}} \right)$, respectively. The numbers of samples thus obtained in the corresponding negative subsets are much greater, and hence the benchmark datasets would be very imbalanced. Using such highly skewed benchmark dataset to train predictors would lead to the outcome that many positive cases might be mispredicted as negative ones.[@bib42], [@bib44], [@bib56], [@bib67] To balance out the size between the positive subset and the negative subset, we randomly picked out 6,366, 1,130, and 120 from the corresponding negative samples to for the negative subsets $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{1}\text{A}} \right)$, $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{6}\text{A}} \right)$, and $\mathbb{S}_{\text{ξ}}^{-}\left( {\text{m}^{5}\text{C}} \right)$, respectively, as done in Chen et al.[@bib16] and Feng et al.[@bib19]Figure 3An Illustration to Show the Process of Collecting the RNA Samples by Sliding the (2ξ + 1) -nt Scaled Window along an RNA SequenceAdapted from Chou[@bib65] with permission. See the text for further explanation.

Finally, the detailed RNA sequence samples thus obtained for the benchmark dataset $\mathbb{S}_{\text{ξ} = 20}\left( {\text{m}^{1}\text{A}} \right)$, $\mathbb{S}_{\text{ξ} = 20}\left( {\text{m}^{6}\text{A}} \right)$, and $\mathbb{S}_{\text{ξ} = 20}\left( {\text{m}^{5}\text{C}} \right)$ are given in the [Supplemental Materials and Methods](#mmc1){ref-type="supplementary-material"}, which can also be directly downloaded from <http://lin.uestc.edu.cn/server/iRNA-PseColl/dataset.htm>.

Formulating RNA Sequence Samples {#sec3.2}
--------------------------------

One of the most challenging problems in computational biology today is how to formulate a biological sequence with a vector that can reflect its key pattern important for the function or mechanism concerned. The importance of such a challenge is due to the fact that nearly all the existing machine-learning algorithms were developed to handle vector rather than sequence samples, as elucidated in a review article.[@bib54] Unfortunately, a vector defined in a discrete model may lose many important sequence pattern features. To deal with such a problem for protein/peptide sequences, the pseudo amino acid composition (PseAAC)[@bib68], [@bib69], [@bib70], [@bib71], [@bib72] was developed. Ever since it was introduced, the concept of PseAAC has penetrated into nearly all the areas of computational proteomics (see a long list of references cited in two review papers[@bib55], [@bib73]). Inspired by the concept of PseAAC and encouraged by its great successes, the pseudo nucleotide composition (PseKNC)[@bib22], [@bib74], [@bib75], [@bib76] was proposed and has been increasingly used in various fields of genome analysis.[@bib20], [@bib21], [@bib23], [@bib37], [@bib39], [@bib40], [@bib42], [@bib43], [@bib51], [@bib52], [@bib53], [@bib58], [@bib59], [@bib60], [@bib77], [@bib78], [@bib79], [@bib80], [@bib81], [@bib82], [@bib83], [@bib84], [@bib85] With both PseAAC and PseKNC being increasingly and widely used, it is highly desired to design a seamless package that can generate various modes of PseAAC and PseKNC according to users' needs for protein/peptide and DNA/RNA sequences, respectively. This was exactly the driving force of establishing the web server called Pse-in-One[@bib86] and what it is about.

The general form of PseKNC for an RNA sequence sample is given by[@bib23]$$\text{R} = \begin{bmatrix}
\text{ϕ}_{1} & \text{ϕ}_{2} & \cdots & \text{ϕ}_{u} & \cdots & \text{ϕ}_{\text{Γ}} \\
\end{bmatrix}^{\mathbf{T}},$$where $\text{T}$ is a transpose operator, while the subscript $\text{Γ}$ an integer and its value as well as the components $\text{ϕ}_{u}$ $\left( {u = 1,\ 2,\ \cdots,\ \text{Γ}} \right)$ will depend on how to extract the desired features from the RNA sequence sample. In order to make [Equation 4](#fd4){ref-type="disp-formula"} able to reflect both the local feature of its individual constituent nucleotides and that of their collective effect, let us define the components in [Equation 4](#fd4){ref-type="disp-formula"} from the following two different approaches.

Local Features of Individual Nucleotides {#sec3.3}
----------------------------------------

RNA consists of four types of nucleotides: A (adenosine), C (cytidine), G (guanosine), and U (uridine). They can be classified into three different categories ([Table 1](#tbl1){ref-type="table"}): (1) from the angle of ring number, A and G have two rings, whereas C and U only one; (2) from the chemical functionality, A and C belong to amino group, while G and U to keto group; and (3) from the angle of hydrogen bonding, C and G can be bonded to each other with three hydrogen bonds, but A and U with only two ([Figure 4](#fig4){ref-type="fig"}). All these properties would have different impacts to RNA's low-frequency internal motion[@bib87], [@bib88] and its biological function[@bib89], [@bib90], [@bib91].Figure 4Illustration to Show the Structure of Paired Nucleic Acid ResiduesLeft: A-U pair bonded to each other with two hydrogen bonds. Right: G-C pair with three hydrogen bonds. Adapted from Chou[@bib87] with permission.

To reflect the aforementioned features, let us denote the *i*-th nucleotide of [Equation 1](#fd1){ref-type="disp-formula"} by[@bib92], [@bib93]$$\text{N}_{i} = \left( {x_{i},\ y_{i},\ z_{i}} \right),$$where $x_{i}$, $y_{i}$, and $z_{i}$ refer to the attributes of (1) ring structure, (2) functional group, and (3) hydrogen bonding in [Table 2](#tbl2){ref-type="table"}, respectively. Accordingly, the nucleotide A can be formulated as (1, 1, 1), C as (0, 1, 0), G as (1, 0, 0), and U as (0, 0, 1); or generally we have$$\begin{matrix}
{x_{i} = \left\{ \begin{matrix}
{1,\ if\ \text{N}_{i} \in \left\{ {A,\ G} \right\}} \\
{0,\ if\ \text{N}_{i} \in \left\{ {C,\ U} \right\}} \\
\end{matrix} \right.;} & {y_{i} = \left\{ {\begin{matrix}
{1,\ if\ \text{N}_{i} \in \left\{ {A,\ C} \right\}} \\
{0,\ if\ \text{N}_{i} \in \left\{ {G,\ U} \right\}} \\
\end{matrix};} \right.} \\
{z_{i} = \left\{ \begin{matrix}
{1,\ if\ \text{N}_{i} \in \left\{ {A,\ U} \right\}} \\
{0,\ if\ \text{N}_{i} \in \left\{ {C,\ G} \right\}} \\
\end{matrix} \right..} & \\
\end{matrix}$$Table 2Classification of NucleotidesAngle of ViewAttributeNucleotides(1) Ring structurepurineA, GpyrimidineC, U(2) Functional groupaminoA, CketoG, U(3) Hydrogen bondingstrongerC, GweakerA, U[^3]

Collective Features of the Constituent Nucleotides {#sec3.4}
--------------------------------------------------

There are some methods to reflect the coupling of a biological sequence or the collective effect of its constituent elements, such as the conditional probability approach,[@bib94] degenerate Kmer strategy,[@bib40] and g-gap dipeptide mode.[@bib41] In this study, we would like to use a different approach; i.e., consider the occurrence frequency of a nucleotide not only for its local site but also for its distribution along the sequence of an RNA sample, as defined by the following equation$$D_{i} = \frac{1}{\left\| L_{i} \right\|}\sum_{j = 1}^{\ell}{f\left( N_{j} \right)},$$where $D_{i}$ is the density of the nucleotide $\text{N}_{i}$ at the site $i$ of a RNA sequence, $\left\| L_{i} \right\|$ the length of the sliding substring concerned, $\ell$ denotes each of the site locations counted in the substring, and$$f\left( N_{j} \right) = \left\{ \begin{array}{l}
{1,\quad\text{if}\ N_{j} = \text{the}\ \text{nucleotide}\ \text{concerned}} \\
{0,\quad\text{otherwise}} \\
\end{array} \right..$$

For instance, suppose a RNA sequence is "CACGUC." The density of "A" at the sequence position 1, 2, 3, 4, 5, or 6 is $0 = 0/1$, $0.5 = 1/2$, $0.33 \approx 1/3$, $0.25 = 1/4$, $0.20 = 1/5$, or $0.16 = 1/6$, respectively; that of "C" is $1 = 1/1$, $0 = 0/2$, $0.66 \approx 2/3$, $0.5 = 2/4$, $0.4 = 2/5$ or $0.5 = 3/6$, respectively; and so forth.

By combing [(Equation 6)](#fd6){ref-type="disp-formula"}, [(Equation 9)](#fd9){ref-type="disp-formula"}, the *i*-th nucleotide of [Equation 1](#fd1){ref-type="disp-formula"} can be uniquely defined by a set of four variables; i.e.,$$\text{N}_{i} = \left( {x_{i},\ y_{i},\ z_{i},\ D_{i}} \right).$$

For example, the RNA sequence "CACGUC" can be expressed by the following five sets of digital numbers: (0, 1, 0, 1), (1, 1, 1, 0.5), (0, 1, 0, 0.66), (1, 0, 0, 0.25), (0, 0, 1, 0.2), and (0, 1, 0, 0.5). Submitting these numbers into [Equation 5](#fd5){ref-type="disp-formula"}, we have$$\text{R}\left( \text{CACGUC} \right) = \left\lbrack {0\ 1\ 0\ 1\ 1\ 1\ 1\ 0.5\ 0\ 1\ 0\ 0.66\ 1\ 0\ 0\ 0.25\ 0\ 0\ 1\ 0.2\ 0\ 1\ 0\ 0.5} \right\rbrack^{\mathbf{T}},$$meaning that the 6-nt nucleotide example can be defined by a $6 \times 4 = 24$ -D (dimensional) PseKNC vector.

Accordingly, all the samples in the current benchmark datasets ([Supplemental Materials and Methods](#mmc1){ref-type="supplementary-material"}) can be formulated with a $41 \times 4 = 164$ -D vector.

Operation Engine {#sec3.5}
----------------

The prediction was operated by SVM (support vector machine), which has been widely used in various areas of bioinformatics and computational biology.[@bib20], [@bib40], [@bib42], [@bib59], [@bib67], [@bib77], [@bib78], [@bib79], [@bib80], [@bib81], [@bib95], [@bib96], [@bib97], [@bib98], [@bib99], [@bib100], [@bib101], [@bib102], [@bib103] Its basic idea has been elaborated in the aforementioned the papers, and there is no need to repeat it here.

In the current study, the LibSVM package 3.18 was used to implement SVM, which can be downloaded for free from [http://www.csie.ntu.edu.tw/∼cjlin/libsvm/](http://www.csie.ntu.edu.tw/%7Ecjlin/libsvm/){#intref0020}. The SVM algorithm contains two uncertain quantities: one is the regularization parameter $C$ and the other is the kernel width parameter $\text{γ}$. They were optimized via an optimization procedure using the grid search approach as described by$$\begin{cases}
{2^{- 5} \leq C \leq 2^{15}} & {{with}\ {step}\ \Delta C = 2} \\
{2^{- 15} \leq \text{γ} \leq 2^{- 5}} & {{with}\ {step}\ \text{Δγ} = 2^{- 1}} \\
\end{cases},$$where $\Delta C$ and $\text{Δγ}$ represent the step gaps for *C* and $\text{γ},$ respectively.

For those readers who are interested in knowing more about SVM, see Chou and Cai[@bib104] and Cai et al.[@bib105] or a monograph[@bib106] where a brief introduction or detailed description were given, respectively.

The platform predictor obtained via the aforementioned procedures is called "iRNA-PseColl," where "i" stands for "identify," "Pse" for "pseudo component approach," and "Coll" for "collective effects of nucleotides."

Quality Control or Examination {#sec3.6}
------------------------------

Quality control is a very important process in industries; it is even more important for a predictor. To deal with this problem, we need to address the following two issues: (1) what standard or metrics should we adopt to measure the predictor's quality, and (2) what test process or method we should take to calculate the metrics. Below, we address the two problems.

### A Set of Four Intuitive Metrics {#sec3.6.1}

The current prediction is belonging to the category called "binary classification" widely existing in genome analyses. To measure the prediction quality of this kind, a set of four metrics are usually used in literature[@bib107]: (1) sensitivity or Sn, (2) specificity or Sp, (3) overall accuracy or Acc, and (4) Mathew's correlation coefficient or MCC. Unfortunately, their formulations were directly taken from mathematical literature and difficult to be understood by most biological scientists. Fortunately, using the symbols introduced by Chou[@bib108] in studying signal peptides, Xu et al.[@bib109] and Chen et al.[@bib110] have derived a new set of metrics that is equivalent to the old one but much more intuitive and easier to be understood by most biologists, as given below

To address this, we need to consider two issues: one is what metrics should be used to reflect the predictor's success rates; the other is what test method should be adopted to derive the metrics rates.

To quantitatively evaluate the quality of a binary classification predictor, four metrics are generally needed.[@bib107] They are: (1) Acc for the predictor's overall accuracy; (2) MCC for its stability; (3) Sn for its sensitivity; and (4) Sp for its specificity. Unfortunately, the conventional formulations for the four metrics are not quite intuitive, and most biologists have difficulty understanding them, particularly the stability of MCC. Fortunately, as elaborated in Yu et al.[@bib109] and Chen et al.,[@bib110] by using the Chou's[@bib111] symbols and derivation in studying signal peptides, the conventional metrics can be converted into a set of four intuitive equations, as formulated below:$$\begin{cases}
{Sn = 1 - \frac{\mathit{N}_{-}^{+}}{\mathit{N}^{+}}} & {0 \leq {Sn} \leq 1} \\
{Sp = 1 - \frac{\mathit{N}_{+}^{-}}{\mathit{N}^{-}}} & {0 \leq {Sp} \leq 1} \\
{{Acc} = \Lambda = 1 - \frac{\mathit{N}_{-}^{+} + \mathit{N}_{+}^{-}}{\mathit{N}^{+} + \mathit{N}^{-}}} & {0 \leq {Acc} \leq 1} \\
{{MCC} = \frac{1-\left( {\frac{N_{-}^{+}}{N^{+}} + \frac{N_{+}^{-}}{N^{-}}} \right)}{\sqrt{\left( {1+\frac{N_{+}^{-} - N_{-}^{+}}{N^{+}}} \right)\left( {1+\frac{N_{-}^{+} - N_{+}^{-}}{N^{-}}} \right)}}} & {- 1 \leq {MCC} \leq 1} \\
\end{cases},$$where $N^{+}$ represents the total number of positive samples investigated, $N_{-}^{+}$ is the number of positive samples incorrectly predicted to be the negative, $N^{-}$ is the total number of negative samples investigated, and $N_{+}^{-}$ is the number of the negative samples incorrectly predicted to be the positive.

With the metrics of [Equation 13](#fd13){ref-type="disp-formula"}, the meanings of Sn, Sp, Acc, and MCC have become crystal clear as discussed and used in a series of follow-up studies for many different areas.[@bib20], [@bib21], [@bib38], [@bib40], [@bib42], [@bib44], [@bib45], [@bib46], [@bib47], [@bib48], [@bib49], [@bib56], [@bib57], [@bib61], [@bib67], [@bib80], [@bib82], [@bib84], [@bib97], [@bib99], [@bib112], [@bib113], [@bib114], [@bib115] It is instructive to point out that more multi-label sequence samples have been emerging in system biology and medicine.[@bib49], [@bib116], [@bib117], [@bib118], [@bib119] To deal with this kind of multi-label system, a much more sophisticated set of metrics is needed as elaborated in Chou.[@bib120]

### Jackknife Validation {#sec3.6.2}

Three different cross-validation methods are often adopted in literature. These methods include[@bib24]: (1) an independent dataset test, (2) a subsampling (or K-fold cross-validation) test, and (3) the jackknife test. However, as elucidated in Chou[@bib55] in the above three choices, the jackknife test has been demonstrated to be the least arbitrary that can always yield a unique outcome for a given benchmark dataset. Therefore, the jackknife test has been widely recognized and increasingly adopted by researchers to analyze the quality of various predictors.[@bib83], [@bib103], [@bib121], [@bib122], [@bib123], [@bib124], [@bib125], [@bib126], [@bib127], [@bib128], [@bib129], [@bib130], [@bib131] In view of this, we also used the jackknife test to examine the quality of the current prediction method. The jackknife test can exclude the "memory" effect because both the training dataset and testing dataset in a jackknife system are actually open, and each sample will be, in turn, moved between the two. The arbitrariness problem intrinsic to the independent dataset and subsampling tests[@bib55] no longer exists, because the outcome derived via the jackknife test for a predictor is always the same on a given benchmark dataset.
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[^1]: The results were obtained by the jackknife tests on the three benchmark datasets given in [Supplemental Materials and Methods](#mmc1){ref-type="supplementary-material"}, respectively. Acc, overall accuracy; MCC, Mathew's correlation coefficient; Sn, sensitivity; Sp, specificity.

[^2]: See [Equation 13](#fd13){ref-type="disp-formula"} and the relevant text for the definition of metrics.

[^3]: See [Local Features of Individual Nucleotides](#sec3.3){ref-type="sec"} for further explanation.
